POZEN INC Collaboration Agreements
7 Contracts & Agreements
- Amended and Restated Collaboration and License Agreement for outside of the United States by and between POZEN Inc. and AstraZeneca AB dated as of November 18, 2013 (Filed With SEC on March 6, 2014)
- Amended and Restated Collaboration and License Agreement for the United States by and between POZEN Inc. and AstraZeneca AB dated as of November 18, 2013 (Filed With SEC on March 6, 2014)
- Amendment No. 1 to Amended and Restated Collaboration and License Agreement for the United States by and between POZEN Inc. and Horizon Pharma U.S.A. Inc. dated as of November 18,... (Filed With SEC on March 6, 2014)
- License and Collaboration Agreement between POZEN Inc. and sanofi-aventis U.S. LLC, dated as of September 3, 2013 (Filed With SEC on November 6, 2013)
- First Amendment No. 3 to the Collaboration and License Agreement between POZEN Inc. and AstraZeneca AB, dated as of September 16, 2013 (Filed With SEC on November 6, 2013)
- AMENDMENTNO. 2 TO THE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 4, 2008)
- Amendment No. 1 to the Collaboration and License Agreement, dated September 6, 2007, between the Registrant and AstraZeneca, AB (Filed With SEC on November 5, 2007)
